First Time Loading...

Prometheus Biosciences Inc
NASDAQ:RXDX

Watchlist Manager
Prometheus Biosciences Inc Logo
Prometheus Biosciences Inc
NASDAQ:RXDX
Watchlist
Price: 199.92 USD 0.09% Market Closed
Updated: Apr 30, 2024

Prometheus Biosciences Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Prometheus Biosciences Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Prometheus Biosciences Inc
NASDAQ:RXDX
Cash from Financing Activities
$562.2m
CAGR 3-Years
286%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
$21B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-88%
CAGR 10-Years
N/A

See Also

What is Prometheus Biosciences Inc's Cash from Financing Activities?
Cash from Financing Activities
562.2m USD

Based on the financial report for Dec 31, 2022, Prometheus Biosciences Inc's Cash from Financing Activities amounts to 562.2m USD.

What is Prometheus Biosciences Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
286%

Over the last year, the Cash from Financing Activities growth was 110%. The average annual Cash from Financing Activities growth rates for Prometheus Biosciences Inc have been 286% over the past three years .